Skip to Content

Hypromellose Ophthalmic Solution

Last Updated: April 28, 2020
Status: Current

Products Affected - Description
    • Gonak, Akorn, 2.5%, 15 mL NDC 17478-0064-12
    • Goniosoft, OCuSOFT, 2.5%, 15 mL NDC 54799-0503-15
    • Goniotaire, Altaire, 2.5%, 15 mL NDC 59390-0182-13
Reason for the Shortage
    • Akorn has Gonak on shortage due to lack of raw materials.1
    • HUB Pharmaceuticals is planning on relaunching Goniovisc in late-2020.2
    • Altaire has Goniotaire on shortage due to a voluntary recall.[3]
    • OcuSoft did not provide a reason for the shortage.[4]
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Akorn has Gonak 2.5% ophthalmic solution 15 mL bottles on allocation.1
    • Altaire has Goniotaire 2.5% ophthalmic solution 15 mL bottles on back order and the company cannot estimate a release date.[3]
    • Hub Pharmaceuticals has Goniovisc on long-term back order and the company estimates a relaunch date of early-2021.[2]
    • OCuSOFT has Goniosoft 2.5% ophthalmic solution on back order and the company cannot estimate a release date.4

Alternative Agents & Management

    • Hypromellose-containing products are used in ocular examinations and to treat dry eye.[5] There are products available ranging from hypromellose 0.2% to 2.5%.[5] The American Academy of Ophthalmology does not recommend a specific product over another.[6] Use products without preservatives if applying more than 4 times daily.[6]

References

    1. Akorn (personal communication). June 8, July 13, September 7, October 25, December 13 and 26, 2018; March 1, May 8, July 29, September 17, December 18, 2019; January 30, and April 27, 2020.
    2. HUB Pharmaceuticals (personal communication). June 8, July 11, September 5, October 25, December 13, 2018; May 8, July 29, September 13, October 2, December 18, 2019; January 28, and April 27, 2020.
    3. Altaire Pharmaceuticals (personal communication). June 8, July 11, September 5, October 25, December 13, 2018; May 8 and 22, September 17, and December 18, 2019.
    4. Ocusoft/Cynacon (personal communication). June 8, July 11, September 5, October 25, December 13, 2018; May 8, July 29, September 17, and December 18, 2019.
    5. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc; 2018.
    6. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Patern Guidelines. Dry Eye Syndrome. American Academy of Ophthalmology website. www.aao.org/ppp. 2013. Accessed June 11, 2018.

Updated

Updated April 28, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 8, 2018 by Anthony Trovato, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide